Search Results
Jun 03, 2026, 09:36 ET Micro-Dyn, a leader in healthcare claims pricing software, announces its acquisition of CMSPricer.
WILMINGTON, Del., June 3, 2026 /PRNewswire/ -- Micro-Dyn Medical Systems, LLC (Micro-Dyn), an industry leader serving over 200 healthcare organizations in contract management and claims pricing solutions, announced its acquisition
More news about: Micro-Dyn Medical Systems, LLC
Jan 27, 2026, 09:00 ET Forward Networks Closes Record 2025 as Multi-Year Deals Surge 175 Percent
scale rapidly inside the business. Condon led sales at Fastly during the revenue surge that supported its successful IPO and previously helped scale Dyn ahead of its acquisition by Oracle.2025 Award RecognitionForward Networks received several industry recognitions in 2025 for innovation,
More news about: Forward Networks, Inc.
Jan 27, 2026, 09:00 ET Forward Networks Closes Record 2025 as Multi-Year Deals Surge 175 Percent
scale rapidly inside the business. Condon led sales at Fastly during the revenue surge that supported its successful IPO and previously helped scale Dyn ahead of its acquisition by Oracle.2025 Award RecognitionForward Networks received several industry recognitions in 2025 for innovation,
More news about: Forward Networks, Inc.
Jan 26, 2026, 07:18 ET Pociągnięcie pędzla warte miliard dolarów: stworzona przez prawnika platforma aukcji dzieł sztuki zgromadziła oferty na kwotę ponad 1 mld USD już w pierwszym miesiącu działalności i wszystko wskazuje na jej dalszy dynamiczny rozwój
content:https://www.prnewswire.com/news-releases/pocignicie-pdzla-warte-miliard-dolarow-stworzona-przez-prawnika-platforma-aukcji-dzie-sztuki-zgromadzia-oferty-na-kwot-ponad-1-mld-usd-ju-w-pierwszym-miesicu-dziaalnoci-i-wszystko-wskazuje-na-jej-dalszy-dynamiczny-rozwo-302669996.html
More news about: Lloyds Auctions
Nov 25, 2025, 09:00 ET Forward Networks Appoints Bobby Condon as Chief Revenue Officer to Accelerate Global Adoption of Transformational Network Digital Twin Technology
worldwide. At Fastly, Condon played a key role in the company's growth from early scale-up through its successful public offering. Before that, he helped Dyn address core Internet performance and scalability challenges and worked with leading digital streaming and media platforms during a period of rapid expansion,
More news about: Forward Networks, Inc.
Aug 16, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Aug 11, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Aug 06, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jul 31, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jul 27, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jul 22, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jul 17, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jul 12, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jul 07, 2025, 15:58 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jul 02, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jun 27, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jun 24, 2025, 03:43 ET Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - DYN
DYN) for violations of the securities laws.
More news about: DJS Law Group LLP
Jun 22, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP